TTY Biopharm Co Ltd (4105) — Capital Reinvestment Ratio
TTY Biopharm Co Ltd (4105) has a Capital Reinvestment Ratio of 0.04x as of December 2025, meaning it reinvests 0% of its operating cash flow (NT$778.89 Million) in capital expenditures (NT$34.72 Million). See TTY Biopharm Co Ltd balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
TTY Biopharm Co Ltd Capital Reinvestment Ratio (2017–2025)
This chart tracks TTY Biopharm Co Ltd's Capital Reinvestment Ratio across 9 annual periods. Check TTY Biopharm Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for TTY Biopharm Co Ltd (2017–2025)
Year-by-year Capital Reinvestment Ratio for TTY Biopharm Co Ltd from 2017 to 2025. For live market cap and broader valuation context, see market cap of TTY Biopharm Co Ltd.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | NT$1.76 Billion | NT$150.83 Million | ▼ -14.0% |
| 2024 | 0.10x | NT$1.35 Billion | NT$134.29 Million | ▲ +8.5% |
| 2023 | 0.09x | NT$1.09 Billion | NT$99.58 Million | ▼ -16.3% |
| 2022 | 0.11x | NT$1.24 Billion | NT$135.50 Million | ▲ +85.8% |
| 2021 | 0.06x | NT$1.26 Billion | NT$74.15 Million | ▼ -82.9% |
| 2020 | 0.35x | NT$526.35 Million | NT$181.86 Million | ▲ +498.3% |
| 2019 | 0.06x | NT$1.21 Billion | NT$69.86 Million | ▼ -16.3% |
| 2018 | 0.07x | NT$1.07 Billion | NT$74.09 Million | ▼ -29.0% |
| 2017 | 0.10x | NT$996.52 Million | NT$96.79 Million | — |